About BioConsortia
BioConsortia is a private company based in Davis, California. It has reported $41,000,009 raised in four offerings on Form D since October 2016.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Apr 17, 2023 | Apr 20, 2023 | $15,000,000fully sold | 1 | $15.0M | EquityRule 506(b) | Form D ↗ |
| Mar 26, 2019 | Mar 27, 2019amended Mar 27, 2019 | $8,000,000fully sold | 3 | $2.6M | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Mar 2, 2018 | Mar 13, 2018 | $10,000,010fully sold | 3 | $3.3M | EquityRule 506(b) | Form D ↗ |
| Oct 25, 2016 | Oct 27, 2016 | $7,999,999fully sold | 5 | $1.5M | EquityRule 506(b) | Form D ↗ |
| Total, four offerings | $41,000,009 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on BioConsortia's Form D filed Apr 20, 2023.
MS
Marcus Meadows-Smith
Executive officer and director
CH
Christina Huben
Chief Financial Officer
JP
John Pasquesi
Director
Earlier filings also listed Tamara Tompkins (director, last listed Oct 2016).